Blockchain Technology for Strengthening the Indian Generic Medicine Supply Chain and Combating Counterfeit Drugs

Year : 2024 | Volume : 11 | Issue : 03 | Page : 9 12
    By

    Shalini Chawla,

  • Ijasul Haque,

  1. Director Professor, Department of Pharmacology, Maulana Azad Medical College (MAMC), New Delhi, India
  2. Assistant Professor, Department of Pharmacology, MES Medical College, Kerala, India

Abstract

India is one of the leading distributors of generic medicines globally, but its supply chain faces numerous challenges including substandard medicines, counterfeiting, and inefficient logistics. Blockchain technology offers a promising solution by providing a secure, decentralized, and transparent platform to track and verify the entire drug supply chain from production to delivery. This paper investigates the potential of blockchain to mitigate counterfeit drug circulation, improve trust in Indian generic medicines, and enhance the efficiency of supply chain management. It explores real-world applications, such as NITI Aayog’s collaboration with Oracle and other blockchain initiatives globally. The paper concludes that blockchain can restore stakeholder confidence, address counterfeiting challenges, and position India as a leader in global pharmaceutical supply chains while improving public health outcomes through better product traceability. By embracing blockchain, the Indian pharmaceutical industry can revolutionize drug distribution and contribute to a safer global medicine supply chain.

Keywords: Blockchain, Indian generic drugs, counterfeit drugs, anti-counterfeiting, pharmaceutical supply chain

[This article belongs to Research & Reviews: A Journal of Drug Formulation, Development and Production ]

How to cite this article:
Shalini Chawla, Ijasul Haque. Blockchain Technology for Strengthening the Indian Generic Medicine Supply Chain and Combating Counterfeit Drugs. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2024; 11(03):9-12.
How to cite this URL:
Shalini Chawla, Ijasul Haque. Blockchain Technology for Strengthening the Indian Generic Medicine Supply Chain and Combating Counterfeit Drugs. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2024; 11(03):9-12. Available from: https://journals.stmjournals.com/rrjodfdp/article=2024/view=180363


References

  1. Gambia child deaths: WHO stands by “dangerous” India cough syrup claim. BBC News [Internet]. 2022 Dec 16 [Accessed on March 2023]. Available from: https://www.bbc.com/news/world-asia-india-63996180.
  2. World Health Organization. Substandard and falsified medical products [Internet]. [Accessed on March 2023]. Available from: https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products.
  3. Khan AN, Khar RK. Current scenario of spurious and substandard medicines in India: a systematic review. Indian J Pharm Sci. 2015;77(1):2–7. doi: 10.4103/0250-474x.151550.
  4. Guidelines for Spurious Drugs [Internet]. [Accessed on March 2023]. Available from: https://cdsco.gov.in/opencms/opencms/en/consumer/Guidelines-for-Spurious-Drugs/.
  5. DGFT Drug Track N Trace Implementation Manual [Internet]. [Accessed on March 2023]. Available from: http://dava.gov.in/davahq/files/DGFT_Drug_Track_N_Trace_Implementation_Manual.pdf
  6. Sainathan P. Tackling counterfeit medicines—barcodes vs. RFID vs. blockchain [Internet]. [Accessed on March 2023]. Available from: https://blog.roambee.com/supply-chain-technology/tackling-counterfeit-medicines-barcodes-vs-rfid-vs-blockchain.
  7. Ghosh J. The blockchain: opportunities for research in information systems and information technology. J Glob Inf Technol Manag. 2019;22(4):235–242. doi: 10.1080/1097198X.2019.1679954
  8. Nakamoto S. Bitcoin: a peer-to-peer electronic cash system [Internet]. [Accessed on March 2023]. Available from: https://bitcoin.org/bitcoin.pdf.
  9. Sheikh H, Azmathullah RM, Rizwan F. Proof-of-work vs proof-of-stake: A comparative analysis and an approach to blockchain consensus mechanism. Int J Res Appl Sci Eng Technol. 2018;6(12):786–791.
  10. Khan SN, Loukil F, Ghedira-Guegan C, Benkhelifa E, Bani-Hani A. Blockchain smart contracts: Applications, challenges, and future trends. Peer-to-Peer Netw Appl. 2021;14(5):2901–2925. doi: 10.1007/s12083-021-01127-0.
  11. Zakari N, Al-Razgan M, Alsaadi A, Alshareef H, Al saigh H, Alashaikh L, et al. Blockchain technology in the pharmaceutical industry: A systematic review. PeerJ Comput Sci. 2022;8:e840. doi: 7717/peerj-cs.840.
  12. 5 transformative merits of blockchain in pharma [Internet]. BioSpectrum Asia. [Accessed on March 2023]. Available from: https://www.biospectrumasia.com/analysis/25/20238/5-transformative-merits-of-blockchain-in-pharma-.html.
  13. NITI Aayog, Oracle, Apollo Hospitals and Strides Pharma Sciences come together to end India’s growing battle against fake drug distribution [Internet]. Oracle. [Accessed on March 2023]. Available from: https://www.oracle.com/in/corporate/pressrelease/niti-aayog-oracle-pilot-real-drug-supply-chain-with-blockchain-iot-2018-09-28.html.
  14. Xu J, Guo S, Xie D, Yan Y. Blockchain: A new safeguard for agri-foods. Artif Intell Agric. 2020;4:153–161. doi: 1016/j.aiia.2020.08.002.
  15. Carrefour goes the blockchain way [Internet]. WhatNext Global. 2022 [Accessed on March 2023]. Available from: https://whatnextglobal.com/carrefour-goes-the-blockchain-way/.
  16. Ahmed WAH, MacCarthy BL. Blockchain-enabled supply chain traceability–how wide? how deep? Int J Prod Econ. 2023;263:108963.
Regular Issue Subscription Original Research
Volume 11
Issue 03
Received 18/09/2024
Accepted 10/10/2024
Published 28/10/2024
323

Login


My IP

PlumX Metrics